Alkem Laboratories rises on reporting around 3-fold jump in Q4 consolidated net profit

30 May 2019

Alkem Laboratories is currently trading at Rs. 1768.00, up by 42.90 points or 2.49% from its previous closing of Rs. 1725.10 on the BSE.

The scrip opened at Rs. 1727.05 and has touched a high and low of Rs. 1798.00 and Rs. 1721.55 respectively. So far 6246 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 2265.00 on 10-Sep-2018 and a 52 week low of Rs. 1674.00 on 17-May-2019.

Last one week high and low of the scrip stood at Rs. 1798.00 and Rs. 1675.00 respectively. The current market cap of the company is Rs. 21276.59 crore.

The promoters holding in the company stood at 66.02%, while Institutions and Non-Institutions held 7.79% and 26.20% respectively.

The company has reported 3-fold jump in its net profit at Rs 190.82 crore for the quarter ended March 31, 2019 as compared to Rs 59.99 crore for the same quarter in the previous year. Total income of the company increased by 25.99% at Rs 1,486.91 crore for Q4FY19 as compared Rs 1,180.17 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported around 3-fold jump in its net profit at Rs 170.50 crore for the quarter under review as compared to Rs 66.33 crore for the same quarter in the previous year. Total income of the company increased by 23.76% at Rs 1,881.86 crore for Q4FY19 as compared Rs 1,520.56 crore for the corresponding quarter previous year.

For the year ended March 31, 2019, the company has reported a rise of 11.73% in its net profit at Rs 799.84 crore as compared to Rs 715.84 crore for the previous year. Total income of the company increased by 7.43% at Rs 5,781.67 crore for year under review as compared to Rs 5,381.92 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has reported a rise of 21.18% in its net profit at Rs 773.64 crore as compared to Rs 638.42 crore for the previous year. Total income of the company increased by 14.25% at Rs 7,444.89 crore for year under review as compared to Rs 6,516.59 crore for year ended March 31, 2018.

Related Alkem Laboratories Ltd. Links:

Alkem Laboratories Share Price

2779.05 -0.35 (-0.01%) Sep 30, 18:01
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 500.50
Dr. Reddys Lab 5187.05
Lupin 1007.10
Piramal Enterprises 1251.95
Cadila Healthcare 394.90
View more..
Sensex vs Alkem Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback